Pazopanib plus bevacizumab shows promise as a first-line treatment for kidney cancer
Results from a phase 2 study of pazopanib alternated with [...]
Results from a phase 2 study of pazopanib alternated with [...]
To date, there have not been any studies that have [...]
The treatment of heavily pretreated patients with metastatic kidney cancer [...]
Papillary renal cell carcinoma (pRCC) is the most common subtype [...]
This year’s American Society of Clinical Oncology Genitourinary Cancers (ASCO [...]
A recent clinical trial looked at a new anti-cancer medication [...]
Translocation kidney cancer is a rare type of kidney cancer [...]
Nearly 30% of new kidney cancer cases are diagnosed at [...]
In many countries, combinations of VEGFR TKI anti-cancer mediations plus [...]
Immunotherapy combinations are becoming the standard treatment for people with [...]